BIM
MR

BlackRock Investment Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

BlackRock Investment Management’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,852
Closed -$213K – 4149
2015
Q4 		$213K Buy
7,852
+2,383
+44% +$61.4K ﹤0.01% 3219
2015
Q3 		$120K Sell
5,469
-1,321
-19% -$33.7K ﹤0.01% 3294
2015
Q2 		$194K Sell
6,790
-126,155
-95% -$3.68M ﹤0.01% 3273
2015
Q1 		$3.64M Sell
132,945
-22,925
-15% -$631K ﹤0.01% 1611
2014
Q4 		$4.12M Sell
155,870
-417
-0.3% -$12.2K 0.01% 1513
2014
Q3 		$4.71M Sell
156,287
-166
-0.1% -$5.14K 0.01% 1373
2014
Q2 		$4.93M Buy
156,453
+66,655
+74% +$2.12M 0.01% 1402
2014
Q1 		$2.91M Buy
89,798
+3,252
+4% +$114K ﹤0.01% 1781
2013
Q4 		$3.15M Buy
86,546
+80,757
+1,395% +$3.14M ﹤0.01% 1685
2013
Q3 		$225K Buy
5,789
+1,460
+34% +$58.8K ﹤0.01% 3166
2013
Q2 		$162K Buy
+4,329
New +$171K ﹤0.01% 3189

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock Investment Management's MR Position: Q1 2016 in Review

BlackRock Investment Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 7,852 shares — an estimated $213K sold.

BlackRock Investment Management first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $4.93M in Q2 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • BlackRock Investment Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 7,852 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $213K.
  • BlackRock Investment Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • BlackRock Investment Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $4.93M in Q2 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on BlackRock Investment Management's 13F filing for Q1 2016, filed 10 May 2016.